Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG).

Trial Profile

Aspirin and Plavix Following Coronary Artery Bypass Grafting (ASAP-CABG).

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 20 May 2015

At a glance

  • Drugs Aspirin (Primary) ; Clopidogrel (Primary)
  • Indications Coronary artery disease; Coronary thrombosis
  • Focus Therapeutic Use
  • Acronyms ASAP-CABG
  • Most Recent Events

    • 18 May 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 07 Mar 2014 Planned End Date changed from 1 Jul 2014 to 1 Jul 2015 as reported by ClinicalTrials.gov.
    • 06 Feb 2013 Planned end date changed from 1 Jul 2012 to 1 Jul 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top